Work

Physiopathology of Phosphate Disorders

Year: 2023

Type: article

Source: Advances in Kidney Disease and Health

DOI: 10.1053/j.akdh.2022.12.011

Authors: Ignacio Portales-Castillo, Timo Rieg, Sheikh B. Khalid, Sagar U. Nigwekar, Javier A. Neyra

Institutions: Harvard University, Massachusetts General Hospital, University of South Florida, James A. Haley Veterans' Hospital, Indus Hospital, University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Parathyroid Disorders and Treatments

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Veterans Affairs, American Heart Association, Alnylam Pharmaceuticals, Inozyme Pharma, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Biomedical Imaging and Bioengineering

Awards: G1144218730, Reducing Chronic Pain and Opioid Use in Hemodialysis Patients, G2667374599, G2855615985, G3758415696, G4259817182, G5272248376, G6107799366, Pharmacological Npt2a inhibition as an approach for treating impaired phosphate homeostasis, G6427486865, Coordinating Unit for DiaComp, UAB-UCSD O'Brien Center for Acute Kidney Injury Research, G7756991352, Coordinating and Bioinformatics Unit for the AMDCC/MMPC, NMR-Based Rapid Fluid Assessment: Device Design and Signal Processing, The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial

OpenAlex ID: W4322734150

FWCI: 4.241

Cites: 93

Cited by: 26

Related to: 10